Press releases
- Haemonetics Prices Upsized Private Placement of $600 Million Convertible Senior Notes
- Haemonetics Announces Proposed Convertible Senior Notes Offering
- Haemonetics 4th Quarter and Fiscal Year 2024 Earnings Release Available on Investor Relations Website
- Haemonetics Sets Date for Publishing Fourth Quarter and Fiscal Year 2024 Results: May 9, 2024
- Haemonetics Receives FDA Clearance for New TEG® 6s Global Hemostasis - HN Cartridge
- Haemonetics Corporation Completes Acquisition of Attune Medical
More ▼
Key statistics
As of last trade Haemonetics Corp (HAZ:FRA) traded at 79.00, -11.73% below its 52-week high of 89.50, set on May 20, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 77.00 |
---|---|
High | 79.00 |
Low | 77.00 |
Bid | 78.50 |
Offer | 80.00 |
Previous close | 76.50 |
Average volume | 0.00 |
---|---|
Shares outstanding | 50.84m |
Free float | 50.45m |
P/E (TTM) | 36.76 |
Market cap | 4.27bn USD |
EPS (TTM) | 2.29 USD |
Data delayed at least 15 minutes, as of Jun 04 2024 15:13 BST.
More ▼